Reports
Global Addiction Treatment Market Report, Size, Share, Outlook, Forecast: By Treatment Type: Medications, Counseling and Behavioral Therapies, Detoxifications, Others; By Addiction Type; By Route of Administration; By Treatment Centres; By Treatment Channel; By Distribution Channel; Regional Analysis; Supplier Landscape; 2023-2031
Global Addiction Treatment Market Outlook
The global addiction treatment market size attained a value of about USD 6.8 billion in 2022, driven by increasing drug awareness campaigns, development of rehab and addiction centres, and growing initiatives by various governments to prevent overdose. The market is further expected to grow at a CAGR of 6.1% during the forecast period of 2023-2031 to reach nearly USD 11.7 billion by 2031 driven by the increasing prevalence of addiction across the globe.
Addiction Treatment Market: Introduction and Insights
Addiction refers to a neuropsychological disorder that compels an individual to engage in certain activities, coupled with an intense and persistent urge to follow through with the activity. It often results in the neglection of other aspects of life. Addiction can lead to severe physical and psychological damage, including stroke, cancer, HIV/AIDS, hepatitis B and C, lung disease, cardiovascular disease, and mental disorders like depression and stress, among others. This cycle of addition can only be broken by following regular treatment and giving up on substance, either temporarily or permanently, depending on the condition. Since this is a chronic disorder, long term treatment and constant care prove to be beneficial.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Addiction treatment involves medical management of withdrawal symptoms, along with a detailed evaluation of nature of addiction and triggers. Most of the doctors suggest a treatment pathway that can meet the needs of the patient. The factors that decide the kind of treatment that is chosen for the patient includes the kind of addiction, the length and severity of substance use, and its effect on individual health.
Addiction Treatment Market Epidemiology
Addiction can be very dangerous because it has multifaceted dangers associated with it. The prevalence is continuously rising despite the increased awareness about its effects on health.
In America, more than 23 million adults were addicted with drug in 2019, these drugs induced disorders always prevail in nearly 10% of American population. Despite being aware of the deteriorating effects of drug on health, people still do not go for treatment, which is still a major obstacle for the treatment market.
Men are more likely to suffer from addiction due to higher drug and alcohol abuse than women. Based on age, young adults are more prone to addiction, especially people belong to the age group of 18-29, due to rising influence and social pressure. The prevalence starts declining once these people enter their 30s.
Addiction Treatment Market Scenario
North America is anticipated to lead the global addiction treatment market during the forecast period of 2023-2031, driven by the rising prevalence of the condition due to the increased use of substances. The growth of the market is also aided by the rising abuse of substance, along with the increased support from the government to minimise substance abuse, especially among the youth. Within North America, the United States is likely to witness higher growth in the treatment market, driven by the rising initiatives and drives against substance use by the government.
Other regions like Europe and Asia Pacific are also witnessing an upward demand for the treatment market. In the United States, the rising programs and initiatives by the government, both in private and public treatment channels, are bolstering the growth of the addiction treatment channel. In the Asia Pacific region, the population of addicts is rapidly rising, especially in China and India. With the rise in the number of addicts at such alarming speed, the treatment market is a necessity in these regions.
The key trends propelling the growth of the addiction treatment market include growing collaboration between key players of the market so as to develop advanced drug delivery systems and medications to combat addiction. Such collaborations are expected to result in delivery of advanced treatment options.
Increasing investments in research and development activities focusing on recovery process is another key trend in the market for addiction treatment. Such investments have resulted in development of recovery processes that are more effective and significantly reduce the rate of relapse.
The size of addiction treatment market is further expected to grow with the rising number of cases. Economic stress along with loneliness and general anxiety has resulted in increase in number of addiction related cases as dependency on various substances becomes a way for individuals to cope with their problems.
The pain addiction treatment market size is expected to grow exponentially over the forecast period as the number of people suffering from chronic pain increases. This increase in brought on by changing lifestyle and ageing population. Other causes include rising cases of chronic ailments such as cancer, stomach ulcers, and rheumatoid arthritis, among others.
Addiction Treatment Market Segmentations
The market can be segmented on the basis of treatment type, addiction type, route of administration, treatment centres, treatment channel, distribution channel, and major regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Treatment Type
- Medications
- Bupropion
- Varenicline
- Acamprosate
- Disulfiram
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Replacement Products
- Others
- Counselling and Behavioural Therapies
- Cognitive-Behavioural Therapy
- Multi-Dimensional Therapy
- Motivational
- Others
- Detoxifications
- Others
Market Breakup by Addiction Type
- Alcohol Addiction Treatment
- Tobacco/Nicotine Addiction Treatment
- Opioid Addiction Treatments
- Other Addictions
Market Breakup by Route of Administration
- Oral
- Parentals
- Others
Market Breakup by Treatment Centres
- Hospitals
- Specialty Clinics
- Homecare Settings
- Rehabilitation Centres
- Others
Addiction Treatment Market Breakup by Treatment Channel
- Public
- Private
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Market Share by Type of Addiction
Alcohol addiction accounts for a significant share of addiction treatment market as dependency on alcohol can be rapid, aggressive, and can surface over a long period of time. Prolonged consumption of alcohol results in increased reliance of brain on the liquid so as to produce various chemicals. As a result, it becomes very difficult for heavy drinkers to quit drinking as the withdrawal symptoms are extremely severe. Maintaining sobriety is extremely challenging, even after availing treatment, the chances of relapse are high. Awareness about major triggers, along with regular counselling and support groups, can aid in proper management of the addiction.
Market Share by Treatment
According to the global addiction treatment market research, the preferred treatment in overcoming any addiction is detoxification, however the most popular and effective treatment method is counselling and behavioural therapies. Such therapy sessions might occur one on one, or with a group or with family members, depending upon the need of the patient. The intensity and the frequency of the sessions gradually decreases over time as the symptoms improve. Counselling and behavioural therapies are expected to account for a significant share in addiction treatment market value as they help patients in changing their attitudes and behaviour as well as support other modes of treatments.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report gives an in-depth analysis of the key players involved in the addiction treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Takeda Pharmaceutical Company Limited
- F. Hoffmann-La Roche Ltd.
- Abbott
- Medtronic
- Abbott
- BD
- Johnson & Johnson Services, Inc.
- GSK Plc.
- Bayer AG
- Zimmer Biomet
- Stryker Corporation
- Homology Medicines, Inc.
- Novartis AG
- Pfizer Inc.
- JCR Pharmaceuticals Co., Ltd.
- Sangamo Therapeutics
- AVROBIO, Inc.
- REGENXBIO Inc.
- CANbridge Life Sciences Ltd.
- Denali Therapeutics
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Addiction Type |
|
| Breakup by Route of Administration |
|
| Breakup by Treatment Centres |
|
| Breakup by Treatment Channel |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Addiction Diseases Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Addiction Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Addiction Epidemiology (2016-2031)
5.3 Europe Addiction Epidemiology (2016-2031)
5.4 Asia Pacific Addiction Epidemiology (2016-2031)
5.5 Latin America Addiction Epidemiology (2016-2031)
5.6 Middle East and Africa Addiction Epidemiology (2016-2031)
6 Global Addiction Treatment Market Overview
6.1 Global Addiction Treatment Market Historical Value (2016-2022)
6.2 Global Addiction Treatment Market Forecast Value (2023-2031)
7 Global Addiction Treatment Market Landscape
7.1 Addiction Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
8 Addiction Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Addiction Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Addiction Treatment Market Segmentation
11.1 Global Addiction Treatment Market by Treatment Type
11.1.1 Market Overview
11.1.2 Medications
11.1.2.1 Bupropion
11.1.2.2 Varenicline
11.1.2.3 Acamprosate
11.1.2.4 Disulfiram
11.1.2.5 Naltrexone
11.1.2.6 Methadone
11.1.2.7 Buprenorphine
11.1.2.8 Nicotine Replacement Products
11.1.2.9 Others
11.1.3 Counseling and Behavioral Therapies
11.1.3.1 Cognitive -Behavioral Therapy
11.1.3.2 Multi-Dimensional Therapy
11.1.3.3 Motivational
11.1.3.4 Others
11.1.4 Detoxifications
11.1.5 Others
11.2 Global Addiction Treatment Market by Addiction Type
11.2.1 Market Overview
11.2.2 Alcohol Addiction Treatment
11.2.3 Tobacco/Nicotine Addiction Treatment
11.2.4 Opioid Addiction Treatments
11.2.5 Other Addictions
11.3 Global Addiction Treatment Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Parentals
11.3.4 Others
11.4 Global Addiction Treatment Market by Treatment Centres
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Specialty Clinics
11.4.4 Homecare Settings
11.4.5 Rehabilitation Centres
11.4.6 Others
11.5 Global Addiction Treatment Market by Treatment Channel
11.5.1 Market Overview
11.5.2 Public
11.5.3 Private
11.6 Global Addiction Treatment Market by Distribution Channel
11.6.1 Market Overview
11.6.2 Hospital Pharmacy
11.6.3 Retail Pharmacy
11.6.4 Online Pharmacy
11.6.5 Others
11.7 Global Addiction Treatment Market by Region
11.7.1 Market Overview
11.7.2 North America
11.7.3 Europe
11.7.4 Asia Pacific
11.7.5 Latin America
11.7.6 Middle East and Africa
12 North America Addiction Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Addiction Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Addiction Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Addiction Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Addiction Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Takeda Pharmaceutical Company Limited
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 F. Hoffmann-La Roche Ltd.
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Abbott
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Medtronic
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Abbott
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 BD
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Johnson & Johnson Services, Inc.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 GSK Plc.
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Bayer AG
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Zimmer Biomet
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Stryker Corporation
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Homology Medicines, Inc.
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Novartis AG
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
23.14 Pfizer Inc.
23.14.1 Financial Analysis
23.14.2 Product Portfolio
23.14.3 Demographic Reach and Achievements
23.14.4 Mergers and Acquisitions
23.14.5 Certifications
23.15 JCR Pharmaceuticals Co., Ltd.
23.15.1 Financial Analysis
23.15.2 Product Portfolio
23.15.3 Demographic Reach and Achievements
23.15.4 Mergers and Acquisitions
23.15.5 Certifications
23.16 Sangamo Therapeutics
23.16.1 Financial Analysis
23.16.2 Product Portfolio
23.16.3 Demographic Reach and Achievements
23.16.4 Mergers and Acquisitions
23.16.5 Certifications
23.17 AVROBIO, Inc.
23.17.1 Financial Analysis
23.17.2 Product Portfolio
23.17.3 Demographic Reach and Achievements
23.17.4 Mergers and Acquisitions
23.17.5 Certifications
23.18 REGENXBIO Inc.
23.18.1 Financial Analysis
23.18.2 Product Portfolio
23.18.3 Demographic Reach and Achievements
23.18.4 Mergers and Acquisitions
23.18.5 Certifications
23.19 CANbridge Life Sciences Ltd.
23.19.1 Financial Analysis
23.19.2 Product Portfolio
23.19.3 Demographic Reach and Achievements
23.19.4 Mergers and Acquisitions
23.19.5 Certifications
23.20 Denali Therapeutics
23.20.1 Financial Analysis
23.20.2 Product Portfolio
23.20.3 Demographic Reach and Achievements
23.20.4 Mergers and Acquisitions
23.20.5 Certifications
24 Addiction Treatment Market- Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2022, the global market addiction treatment attained a value of USD 6.8 billion.
The market is anticipated to grow at a CAGR of 6.1% during the forecast period of 2023-2031 to reach a value of USD 11.7 billion by 2031.
The major market drivers include increasing drug awareness campaigns, development of rehab and addiction centres, and growing initiatives by various governments to prevent overdose. These market drivers are expected to increase the addiction treatment market price over the forecast period.
The key trends fuelling the growth of the market include growing collaboration between key market players, increasing investments in research and development activities focusing on recovery process, economic stress, anxiety, and loneliness.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America is propelling the market growth.
The key players in the global addiction treatment market include Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Abbott, Medtronic, Abbott, BD, Johnson & Johnson Services, Inc., GSK Plc., Bayer AG, Zimmer Biomet, Stryker Corporation, Homology Medicines, Inc., Novartis AG, Pfizer Inc., JCR Pharmaceuticals Co., Ltd., Sangamo Therapeutics, AVROBIO, Inc., REGENXBIO Inc., CANbridge Life Sciences Ltd., and Denali Therapeutics.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$3499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER